(SRAD) Sportradar - Overview
Stock: Betting Technology, Real-Time Data, Odds Services, Streaming Services, Integrity
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 38.7% |
| Relative Tail Risk | -6.00% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.51 |
| Alpha | -34.00 |
| Character TTM | |
|---|---|
| Beta | 0.799 |
| Beta Downside | 0.984 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.61% |
| CAGR/Max DD | 0.23 |
Description: SRAD Sportradar January 06, 2026
Sportradar Group AG (NASDAQ:SRAD) supplies a broad suite of sports-data and betting-technology services to operators, media firms, and sports organisations across more than 30 markets, spanning North America, Europe, Asia-Pacific, the Middle East, Africa and Latin America. Its product portfolio includes real-time data feeds, pre-match and live odds, iGaming titles (virtual soccer, horse- and dog-racing, basketball, tennis, baseball, cricket), managed betting/trading services, and a full-stack betting platform, as well as media-content solutions, integrity monitoring, and performance-analysis tools for teams and leagues.
Key recent metrics suggest the business is scaling rapidly: 2023 revenue grew ~23% YoY to €1.2 bn, driven largely by a 35% increase in iGaming licensing fees and a 28% rise in data-feed contracts with North-American operators. EBITDA margin expanded to ~22% as the company leverages its proprietary data pipelines to achieve economies of scale. A core sector driver is the continued liberalisation of sports-betting regulations in the United States, where the number of legal jurisdictions rose to 31 in 2023, expanding the addressable market for Sportradar’s betting-technology suite.
For a deeper quantitative assessment, you may want to explore ValueRay’s detailed valuation model for SRAD.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 94.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.55 > 1.0 |
| NWC/Revenue: 12.23% < 20% (prev 18.44%; Δ -6.22% < -1%) |
| CFO/TA 0.16 > 3% & CFO 396.8m > Net Income 94.8m |
| Net Debt (-297.7m) to EBITDA (534.7m): -0.56 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (319.3m) vs 12m ago 0.35% < -2% |
| Gross Margin: 57.04% > 18% (prev 0.62%; Δ 5642 % > 0.5%) |
| Asset Turnover: 52.31% > 50% (prev 46.20%; Δ 6.11% > 0%) |
| Interest Coverage Ratio: 2.63 > 6 (EBITDA TTM 534.7m / Interest Expense TTM 82.9m) |
Altman Z'' 1.74
| A: 0.06 (Total Current Assets 562.9m - Total Current Liabilities 412.8m) / Total Assets 2.42b |
| B: 0.14 (Retained Earnings 327.0m / Total Assets 2.42b) |
| C: 0.09 (EBIT TTM 218.1m / Avg Total Assets 2.35b) |
| D: 0.25 (Book Value of Equity 361.4m / Total Liabilities 1.43b) |
| Altman-Z'' Score: 1.74 = BBB |
Beneish M -3.08
| DSRI: 0.83 (Receivables 163.1m/167.7m, Revenue 1.23b/1.05b) |
| GMI: 1.09 (GM 57.04% / 62.15%) |
| AQI: 1.02 (AQ_t 0.73 / AQ_t-1 0.72) |
| SGI: 1.17 (Revenue 1.23b / 1.05b) |
| TATA: -0.12 (NI 94.8m - CFO 396.8m) / TA 2.42b) |
| Beneish M-Score: -3.08 (Cap -4..+1) = AA |
What is the price of SRAD shares?
Over the past week, the price has changed by -6.18%, over one month by -22.70%, over three months by -25.68% and over the past year by -20.68%.
Is SRAD a buy, sell or hold?
- StrongBuy: 10
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SRAD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32.6 | 91.7% |
| Analysts Target Price | 32.6 | 91.7% |
| ValueRay Target Price | 15.9 | -6.4% |
SRAD Fundamental Data Overview February 02, 2026
P/E Trailing = 51.7429
P/E Forward = 33.557
P/S = 4.364
P/B = 4.5421
Revenue TTM = 1.23b EUR
EBIT TTM = 218.1m EUR
EBITDA TTM = 534.7m EUR
Long Term Debt = 51.9m EUR (from longTermDebt, last quarter)
Short Term Debt = 10.8m EUR (from shortTermDebt, last quarter)
Debt = 62.7m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -297.7m EUR (from netDebt column, last quarter)
Enterprise Value = 4.24b EUR (4.54b + Debt 62.7m - CCE 360.4m)
Interest Coverage Ratio = 2.63 (Ebit TTM 218.1m / Interest Expense TTM 82.9m)
EV/FCF = 21.22x (Enterprise Value 4.24b / FCF TTM 199.9m)
FCF Yield = 4.71% (FCF TTM 199.9m / Enterprise Value 4.24b)
FCF Margin = 16.28% (FCF TTM 199.9m / Revenue TTM 1.23b)
Net Margin = 7.72% (Net Income TTM 94.8m / Revenue TTM 1.23b)
Gross Margin = 57.04% ((Revenue TTM 1.23b - Cost of Revenue TTM 527.6m) / Revenue TTM)
Gross Margin QoQ = 63.93% (prev 55.29%)
Tobins Q-Ratio = 1.75 (Enterprise Value 4.24b / Total Assets 2.42b)
Interest Expense / Debt = 32.50% (Interest Expense 20.4m / Debt 62.7m)
Taxrate = 22.92% (6.68m / 29.1m)
NOPAT = 168.1m (EBIT 218.1m * (1 - 22.92%))
Current Ratio = 1.36 (Total Current Assets 562.9m / Total Current Liabilities 412.8m)
Debt / Equity = 0.06 (Debt 62.7m / totalStockholderEquity, last quarter 985.3m)
Debt / EBITDA = -0.56 (Net Debt -297.7m / EBITDA 534.7m)
Debt / FCF = -1.49 (Net Debt -297.7m / FCF TTM 199.9m)
Total Stockholder Equity = 959.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.04% (Net Income 94.8m / Total Assets 2.42b)
RoE = 9.89% (Net Income TTM 94.8m / Total Stockholder Equity 959.2m)
RoCE = 21.57% (EBIT 218.1m / Capital Employed (Equity 959.2m + L.T.Debt 51.9m))
RoIC = 16.79% (NOPAT 168.1m / Invested Capital 1.00b)
WACC = 9.08% (E(4.54b)/V(4.60b) * Re(8.86%) + D(62.7m)/V(4.60b) * Rd(32.50%) * (1-Tc(0.23)))
Discount Rate = 8.86% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.14%
[DCF Debug] Terminal Value 77.83% ; FCFF base≈172.0m ; Y1≈212.2m ; Y5≈361.4m
Fair Price DCF = 24.38 (EV 5.01b - Net Debt -297.7m = Equity 5.30b / Shares 217.6m; r=9.08% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 11.31 | EPS CAGR: -7.57% | SUE: -1.97 | # QB: 0
Revenue Correlation: 96.32 | Revenue CAGR: 18.95% | SUE: -0.10 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.04 | Chg30d=-0.020 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.48 | Chg30d=+0.000 | Revisions Net=+3 | Growth EPS=+10.6% | Growth Revenue=+22.4%